Canine brucellosis, caused by Brucella canis, is a global infectious and zoonotic disease that poses a significant public health risk due to the close interactions between dogs and humans. In dogs, the disease can lead to abortion outbreaks, reproductive failures, lymphadenopathy, and occasionally osteoarticular issues. Asymptomatic infections are also relatively common. In humans, brucellosis typically presents with a febrile illness and non-specific symptoms such as splenomegaly, fatigue, and weakness. The disease is notably problematic in breeding programs due to reproductive failures, including infertility and abortion, leading to substantial economic losses. Transmission occurs through direct contact with infected bodily fluids, particularly during mating, or via contaminated environments. Diagnosing canine brucellosis accurately is critical and can be achieved using various methods, including bacterial cultures, serological tests like the Rose Bengal Plate Test (RBPT) and Enzyme-Linked Immunosorbent Assay (ELISA), and molecular techniques such as polymerase chain reaction (PCR). Treatment is limited, with neutering and antibiotic therapy being the main approaches, though these do not always ensure complete recovery. Preventive measures are essential and include regular screening of breeding dogs, isolation of infected animals, and strict biosecurity protocols. Given its zoonotic potential, it is crucial for veterinary professionals and pet owners to be aware of the disease. Increased awareness and future research on new diagnostic methods and effective vaccines are vital for improving control strategies and reducing the impact of canine brucellosis on both canine and human health.